NCT02830048View on ClinicalTrials.gov

Low dosE GlibENclamide in Diabetes Part A

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

March 9, 2017

Study Completion Date

March 9, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Glibenclamide

Trial Locations (1)

OX3 7LE

Clinical Research Unit, OCDEM, Churchill Hospital, Oxford

All Listed Sponsors
collaborator

Oxford University Hospitals NHS Trust

OTHER

lead

University of Oxford

OTHER

NCT02830048 - Low dosE GlibENclamide in Diabetes Part A | Biotech Hunter | Biotech Hunter